Do de novo acute myeloid leukemias with normal cytogenetics involve two main prognostic categories distinguished by the presence of erythroblastic and/or megakaryocytic dysplasia?

Neoplasma

Volumn 47, Issue 1, 2000, Pages 41-47

  Lemez P ^a,b   Galikova J ^a   Haas, T ^c  

^a Hospital Jihlava   (Czech Republic)

^b INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION   (Czech Republic)

^c CHARLES UNIVERSITY   (Czech Republic)

Author keywords

De novo acute myeloid leukemia; Erythroblastic dysplasia; Megakaryocytic dysplasia; Normal karyotype; Remission induction; Survival

Indexed keywords

CYTARABINE; DAUNORUBICIN; ETOPOSIDE; MITOXANTRONE; REFADOR; RUBOMYCIN; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; BONE MARROW EXAMINATION; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOGENETICS; DYSPLASIA; ERYTHROBLAST; FEMALE; HUMAN; LEUKEMIA REMISSION; MALE; MEGAKARYOCYTE; PROGNOSIS;

EID: 0342314473     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. BAIN, B.J.: The bone marrow aspirate of healthy subjects. Br. J. Haematol., 94, 1996, 206-209.
2. BENNETT, J.M., CATOVSKY, D., DANIEL, M.T., FLANDRIN, G., GALTON, D.A.G., GRALNICK, H.R., SULTAN, C.: Proposals for the classification of the myelodysplastic syndromes. Br. J. Haematol., 51, 1982, 189-199.
3. BENNETT, J.M., CATOVSKY, D., DANIEL, M.T., FLANDRIN, G., GALTON, D.A.G., GRALNICK, H.R., SULTAN, C.: Proposed revised criteria for the classification of acute myeloid leukemia. Ann. Intern. Med., 103, 1985, 620-624.
4. BERGER, R., BERNHEIM, A., FLANDRIN, G.: Absence d'anomalie chromosomique et leucémie aiguë: Relations avec les cellules médullaires normales. C. R. Acad. Sci. Paris, 290, Série D, 1980, 1557-1559.
5. BLACKSTOCK, A.M., GARSON, M.O.: Direct evidence for involvement of erythroid cells in acute myeloblastic leukemia. Lancet, 2, 1974, 1178-1179.
6. BLOOMFIELD, C.D., LAWRENCE, D, BYRD, J.C., CARROLL, A., PETTENATI, M.J., TANTRAVAHI, R., PATIL, S.R., DAVEY, F.R., BERG, D.T., SCHIFFER, C.A., ARTHUR, D.C., MAYER, R.J.: Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype. Cancer Res., 58, 1998, 4173-1179.
7. BRITO-BABAPULLE, F., CATOVSKY, D., GALTON D.A.G.: Clinical and laboratory features of de novo acute myeloid leukaemia with trilineage myelodysplasia. Br. J. Haematol., 66, 1987, 445-150.
8. CALIGIURI, M.A., STROUT, M.P., GILLILAND, D.G.: Molecular biology of acute myeloid leukemia. Semin. Oncol., 24, 1997, 32-44.
9. CHESON, B.D., CASSILETH, P.A., HEAD, D.R., SCHIFFER, C.A., BENNETT, J.M., BLOOMFIELD, C.D., BRUNNING, R., GALE, R.P., GREVER, M.R., KEATING, M.J., SAWITSKY, A., STASS, S., WEINSTEIN, H., WOODS, W.G.: Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia. J. Clin. Oncol., 8, 1990, 813-819.
10. CLARKSON, B.D.: Current concepts of leukemia and results of recent treatment programs. Transplant. Proc., 10, 1978, 157-162.
11. ESTIENNE, M.H., FENAUX, P., PREUDHOMME, C., LAI, J.L., ZANDECKI, M., LEPELLEY, P., COSSON, A.: Prognostic value of dysmyelopoietic features in de novo acute myeloid leukemia: A report on 132 patients. Clin. Laborat. Haematol., 12, 1990, 57-65.
12. FERRANT, A., LABOPIN, M., FRASSONI, F., PRENTICE, H.G., CAHN, J.Y., BLAISE, D., REIFFERS, J., VISANI, G., SANZ, M.A., BOOGAERTS, M.A., LÖWENBERG, B., GORIN, N.C.: Karyotype in acute myeloblastic leukemia: Prognostic significance for bone marrow transplantation in first remission: A European Group for Blood and Marrow Transplantation study. Blood, 90, 1997, 2931-2938.
13. FIALKOW, P.J., SINGER, J.W., ADAMSON, J.W, VAIDYA, K., Dow, L.W., OCHS, J., MOOHR, J.W.: Acute nonlymphocytic leukemia: Heterogeneity of stem cell origin. Blood, 57, 1981, 1068-1073.
14. Fourth International Workshop on Chromosomes in Leukemia, 1982: A prospective study of acute nonlymphocytic leukemia. Cancer Genet. Cytogenet., 11, 1984, 249-360.
15. FREIREICH, E.J., KEATING, M.J.: Conclusions regarding leukemia long-term survival. Cancer, Suppl., 80, 1997, 2215-2217.
16. GAHN, B., HAASE, D., UNTERHALT, M., DRESCHER, M., SCHOCH, C., FONATSCH, C., TERSTAPPEN, L.W.M.M., HIDDEMANN, W., BÜCHNER, T., BENNETT, J.M., WÖRMANN, B.: De novo AML with dysplastic hematopoiesis: Cytogenetic and prognostic significance. Leukemia, 10, 1996, 946-951.
17. GALE, R.P., HOROWITZ, M.M., WEINER, R.S., ASH, R.C., ATKINSON, K., BABU, R., DICKE, K.A., KLEIN, J.P., LÖWENBERG, B., REIFFERS, J., RIMM, A.A., ROWLINGS, P.A., SANDBERG, A.A., SOBOCINSKI, K.A., VEUM-STONE, J., BORTIN, M.M.: Impact of cytogenetic abnormalities on outcome of bone marrow transplants in acute myelogenous leukemia in first remission. Bone Marrow Transplant., 16, 1995, 203-208.
18. GOASGUEN, J.E., MATSUO, T, COX, C., BENNETT, J.M.: Evaluation of the dysmyelopoiesis in 336 patients with de novo acute myeloid leukemia: Major importance of dysgranulopoiesis for remission and survival. Leukemia, 6, 1992, 520-525.
19. GRIMWADE, D., WALKER, H., OLIVER, F., WHEATLEY, K., HARRISON, C., HARRISON, G., REES, J., HANN, I, STEVENS, R., BURNETT, A., GOLDSTONE, A.: The importance of diagnostic cytogenetics on outcome in AML: Analysis of 1612 patients entered into the MRC AML 10 trial. Blood, 92, 1998, 2322-2333.
20. ISCN: An International System for Human Cytogenetic Nomenclature. Ed.: Mitelman, F. Basel, Karger 1995, 114.
21. JINNAI, I., TOMONAGA, M., KURIYAMA, K., MATSUO, T., NONAKA, H., AMENOMORI, T., YOSHIDA, Y., KUSANO, M., TAGAWA, M., ICHIMARU, M.: Dysmegakaryocytopoiesis in acute leukaemias: Its predominance in myelomonocytic (M4) leukaemia and implication for poor response to chemotherapy. Br. J. Haematol., 66, 1987, 467-472.
22. KROGH JENSEN, M., KILLMANN, S-A.: Chromosome studies in acute leukaemia. Evidence for chromosomal abnormalities common to erythroblasts and leukaemic white cells. Acta Med. Scand., 181, 1967, 47-53.
23. KURIYAMA, K., TOMONAGA, M., MATSUO, T., KOBAYASHI, T., MIWA, H., SHIRAKAWA, S., TANIMOTO, M., ADACHI, K., EMI, N., HIRAOKA, A., TOMINAGA, N., IMAI, K., ASOU, N., TSUBAKI, K., TAKAHASHI, I., MINAMI, S., YOSHIDA, M., MURAKAMI, H., MINATO, K., OSHIMA, T., FURUSAWA, S., OHNO, R., Japan Adult Leukaemia Study Group: Poor response to intensive chemotherapy in de novo acute myeloid leukaemia with trilineage myelodysplasia. Br. J. Haematol., 86, 1994, 767-773.
24. LEMEŽ, P.: Significance of lineage specific differentiation markers for complex classification of acute leukemias. Neoplasma, 37, 1990, 253-281.
25. LEMEŽ, P., GÁLIKOVÁ, J.: Erythroid and/or megakaryocytic dysplasia in de novo acute myeloid leukaemias is a valuable indicator for inclusion of high doses of cytosine arabinoside in induction chemotherapy. Abstract. Histochem. J., 30, 1998, 842.
26. LEMEŽ, P., MICHALOVÁ, K., ZEMANOVÁ, Z., MARINOV, I., TRPÁKOVÁ, A., MORAVCOVÁ, J., JELÍNEK, J.: Three cases of neartetraploid acute myeloid leukemias originating in pluripotent myeloid progenitors. Leuk. Res., 22, 1998, 581-588.
27. LEMEŽ, P., SCHWARZ, J., JELÍNEK, J., MICHALOVÁ, K., VÍTEK, A., VORLOVÁ, Z., PENKA, M., NEUWIRT, J.: Late and slow diagnosis of acute promyelocytic leukemia - main cause of early deaths. Vnitřni Lék., 40, 1994, 654-659.
28. MRÓZEK, K., HEINONEN, K., DE LA CHAPELLE, A., BLOOMFIELD, C.D.: Clinical significance of cytogenetics in acute myeloid leukemia. Semin. Oncol., 24, 1997, 17-31.
29. PALLISGAARD, N., HOKLAND, P., RIISHOJ, D.C., PEDERSEN, B., JORGENSEN, P.: Multiplex reverse transcription-polymerase chain reaction for simultaneous screening of 29 translocations and chromosomal aberrations in acute leukemia. Blood, 92, 1998, 574-588.
30. RAMOS, F., FERNANDEZ-FERRERO, S., SUÁREZ, D., BARBÓN, M., RODRÍGUEZ, J.A., GIL, S., MEGIDO, M., CIUDAD, J., LÓPEZ, N., DEL CAŃIZO, C., ORFAO, A.: Myelodysplastic syndrome: A search for minimal diagnostic criteria. Leuk. Res., 23, 1999, 283-290.
31. SAARNI, M.I., LINMAN, J.W.: Myelomonocytic leukemia: Disorderly proliferation of all marrow cells. Cancer, 27, 1971, 1221-1230.
32. Second MIC Cooperative Study Group: Morphologic, immunologic and cytogenetic (MIC) working classification of the acute myeloid leukaemias. Br. J. Haematol., 68, 1998, 487-494.